Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 26
19
Diseases
29
Unique genes
0.278
Avg. similarity score
Paroxysmal dystonic choreoathetosis
Most-connected disease (11 links)
Disease
Searched: Paroxysmal dystonia
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Paroxysmal dystonia
Paroxysmal dystonic choreoathetosis
Childhood-onset glut1 deficiency syndrome 2
Chromosome 17q23.1-q23.2 deletion syndrome
Epilepsy with myoclonic absence
Episodic kinesigenic dyskinesia
GLUT1 deficiency syndrome
Paroxysmal nonkinesigenic dyskinesia
Familial infantile convulsions with paroxysmal choreoathetosis
Paroxysmal dyskinesia
infantile convulsions and choreoathetosis
Cryohydrocytosis
Epilepsy with myoclonic atonic seizures
Hereditary continuous muscle fiber activity
Cerebellar atrophy with seizures and variable developmental delay
Choreoathetosis
generalized epilepsy-paroxysmal dyskinesia syndrome
Intellectual developmental disorder seizures epilepsy
complex neurodevelopmental disorder with motor features
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Paroxysmal dystonic choreoathetosis | 11 | 11 | 4 |
| Childhood-onset glut1 deficiency syndrome 2 | 9 | 9 | 2 |
| Chromosome 17q23.1-q23.2 deletion syndrome | 7 | 7 | 1 |
| Epilepsy with myoclonic absence | 7 | 7 | 1 |
| Episodic kinesigenic dyskinesia | 7 | 7 | 3 |
| GLUT1 deficiency syndrome | 7 | 7 | 1 |
| Paroxysmal nonkinesigenic dyskinesia | 7 | 7 | 4 |
| Familial infantile convulsions with paroxysmal choreoathetosis | 6 | 6 | 1 |
| Paroxysmal dyskinesia | 5 | 5 | 5 |
| Paroxysmal dystonia | 5 | 5 | 1 |
| infantile convulsions and choreoathetosis | 5 | 5 | 1 |
| Cryohydrocytosis | 4 | 4 | 2 |
| Epilepsy with myoclonic atonic seizures | 4 | 4 | 7 |
| Hereditary continuous muscle fiber activity | 4 | 4 | 1 |
| Cerebellar atrophy with seizures and variable developmental delay | 3 | 3 | 5 |
| Choreoathetosis | 3 | 3 | 6 |
| generalized epilepsy-paroxysmal dyskinesia syndrome | 2 | 2 | 1 |
| Intellectual developmental disorder seizures epilepsy | 1 | 1 | 1 |
| complex neurodevelopmental disorder with motor features | 1 | 1 | 6 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| SLC2A1 | 9 / 19 | Childhood-onset glut1 deficiency syndrome 2, Choreoathetosis, Chromosome 17q23.1-q23.2 deletion syndrome, Cryohydrocytosis and 5 more |
| PRRT2 | 8 / 19 | Childhood-onset glut1 deficiency syndrome 2, Episodic kinesigenic dyskinesia, Familial infantile convulsions with paroxysmal choreoathetosis, infantile convulsions and choreoathetosis and 4 more |
| KCNA1 | 5 / 19 | Episodic kinesigenic dyskinesia, Hereditary continuous muscle fiber activity, Paroxysmal dyskinesia, Paroxysmal dystonic choreoathetosis and 1 more |
| KCNMA1 | 3 / 19 | Cerebellar atrophy with seizures and variable developmental delay, generalized epilepsy-paroxysmal dyskinesia syndrome, Paroxysmal nonkinesigenic dyskinesia |
| AP2M1 | 2 / 19 | Epilepsy with myoclonic atonic seizures, Intellectual developmental disorder seizures epilepsy |
| EMC1 | 2 / 19 | Cerebellar atrophy with seizures and variable developmental delay, complex neurodevelopmental disorder with motor features |
| KCNJ10 | 2 / 19 | Paroxysmal dyskinesia, Paroxysmal dystonic choreoathetosis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Phase 0 - rapid depolarisation | Reactome | 3 / 44 | 28.2× | 1.57e-4 | 3.14e-3 ✓ sig. |
| Dopaminergic synapse | KEGG | 4 / 132 | 12.5× | 2.68e-4 | 4.80e-3 ✓ sig. |
| Presynaptic depolarization and calcium channel opening | Reactome | 2 / 12 | 69.0× | 3.66e-4 | 6.18e-3 ✓ sig. |
| Regulation of insulin secretion | Reactome | 2 / 16 | 51.8× | 6.62e-4 | 9.80e-3 ✓ sig. |
| Synaptic vesicle cycle | KEGG | 3 / 79 | 15.7× | 8.85e-4 | 1.22e-2 ✓ sig. |
| GABAergic synapse | KEGG | 3 / 89 | 14.0× | 1.25e-3 | 1.59e-2 ✓ sig. |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | Reactome | 1 / 1 | 414× | 2.41e-3 | 2.62e-2 ✓ sig. |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | Reactome | 1 / 1 | 414× | 2.41e-3 | 2.62e-2 ✓ sig. |
| Nef mediated downregulation of CD28 cell surface expression | Reactome | 1 / 2 | 207× | 4.82e-3 | 4.27e-2 ✓ sig. |
| Enzymatic degradation of Dopamine by monoamine oxidase | Reactome | 1 / 2 | 207× | 4.82e-3 | 4.27e-2 ✓ sig. |
| Endocrine and other factor-regulated calcium reabsorption | KEGG | 2 / 53 | 15.6× | 7.19e-3 | 5.57e-2 |
| Enzymatic degradation of dopamine by COMT | Reactome | 1 / 3 | 138× | 7.23e-3 | 5.60e-2 |
| Lactose synthesis | Reactome | 1 / 3 | 138× | 7.23e-3 | 5.60e-2 |
| Potassium transport channels | Reactome | 1 / 3 | 138× | 7.23e-3 | 5.60e-2 |
| Reuptake of GABA | Reactome | 1 / 4 | 104× | 9.62e-3 | 6.77e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| transmembrane transport | GO:0055085 | 8 / 557 | 9.3× | 1.46e-6 | 1.13e-4 ✓ sig. |
| neuromuscular process controlling posture | GO:0050884 | 3 / 15 | 129× | 1.51e-6 | 1.16e-4 ✓ sig. |
| monoatomic ion transmembrane transport | GO:0034220 | 7 / 404 | 11.2× | 2.17e-6 | 1.55e-4 ✓ sig. |
| regulation of long-term neuronal synaptic plasticity | GO:0048169 | 3 / 18 | 107× | 2.70e-6 | 1.84e-4 ✓ sig. |
| monoatomic ion transport | GO:0006811 | 8 / 667 | 7.7× | 5.57e-6 | 3.30e-4 ✓ sig. |
| regulation of membrane potential | GO:0042391 | 4 / 85 | 30.3× | 8.68e-6 | 4.72e-4 ✓ sig. |
| action potential | GO:0001508 | 3 / 53 | 36.5× | 7.47e-5 | 2.44e-3 ✓ sig. |
| detection of mechanical stimulus involved in sensory perception of pain | GO:0050966 | 2 / 14 | 92.1× | 2.09e-4 | 5.22e-3 ✓ sig. |
| vesicle-mediated transport in synapse | GO:0099003 | 2 / 15 | 85.9× | 2.41e-4 | 5.76e-3 ✓ sig. |
| startle response | GO:0001964 | 2 / 18 | 71.6× | 3.50e-4 | 7.51e-3 ✓ sig. |
| cardiac muscle cell action potential involved in contraction | GO:0086002 | 2 / 24 | 53.7× | 6.28e-4 | 1.13e-2 ✓ sig. |
| vesicle docking involved in exocytosis | GO:0006904 | 2 / 29 | 44.4× | 9.20e-4 | 1.45e-2 ✓ sig. |
| sodium ion transmembrane transport | GO:0035725 | 3 / 134 | 14.4× | 1.15e-3 | 1.65e-2 ✓ sig. |
| adult walking behavior | GO:0007628 | 2 / 34 | 37.9× | 1.26e-3 | 1.76e-2 ✓ sig. |
| neuronal action potential | GO:0019228 | 2 / 34 | 37.9× | 1.26e-3 | 1.76e-2 ✓ sig. |